6 July 2022 – Up to 28 June 2022, Swissmedic evaluated 15,578 reports on suspected adverse drug reactions (ADRs). 9,678 (62.1 %) were reported to Swissmedic as “not serious”, while 5,900 suspected cases (37.9 %) were classified as “serious”. Most of the reports involved more than one reaction. In total, 48,779 reactions were reported, corresponding to an average of 3.13 reactions per report.

For more information, see here.